Medibank Private Limited (ASX:MPL – Get Free Report) insider Peter Everingham purchased 25,000 shares of Medibank Private stock in a transaction dated Friday, February 27th. The shares were purchased at an average price of A$4.41 per share, with a total value of A$110,250.00.
Medibank Private Stock Performance
The firm has a market capitalization of $11.81 billion, a price-to-earnings ratio of 25.50 and a beta of 0.03.
Medibank Private Announces Dividend
The firm also recently announced a Interim dividend, which will be paid on Tuesday, March 17th. Investors of record on Tuesday, March 17th will be given a dividend of $0.083 per share. This represents a yield of 186.0%. The ex-dividend date is Wednesday, February 25th. Medibank Private’s payout ratio is presently 102.78%.
About Medibank Private
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students.
Featured Articles
- Five stocks we like better than Medibank Private
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Medibank Private Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medibank Private and related companies with MarketBeat.com's FREE daily email newsletter.
